BRIDGEWATER, N.J., July 29 (HSMN NewsFeed) — Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) approved Sculptra®Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smil…
Biopharmaceuticals, Dermatology, FDA
sanofi-aventis, SculptraAesthetic, poly-L-lactic acid, nasolabial fold

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles”
Leave a Comment